« Previous
Next »
Fertility and Sterility
Volume 91, Issue 5
, Pages 1657-1661
, May 2009
The value of vascular endothelial growth factor, pregnancy-associated plasma protein-A, and progesterone for early differentiation of ectopic pregnancies, normal intrauterine pregnancies, and spontaneous miscarriages
References
- Vascular endothelial growth factor in the human oviduct: localization and regulation of messenger RNA expression in vivo. Biol Reprod. 2003;68:1870–1876
- . Novel placental and nonplacental serum markers in ectopic versus intrauterine pregnancy. Fertil Steril. 2004;81:1106–1111
- . Evidence-based management of ectopic pregnancy. Curr Opin Obstet Gynecol. 2000;12:289–292
- . Serum vascular endothelial growth factor as a possible marker for early ectopic pregnancy. Hum Reprod. 2002;17:490–492
- . Ectopic pregnancy: ten common pitfalls in diagnosis. Am J Emerg Med. 1990;8:515–522
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435–439
- . A longitudinal study of maternal serum VEGF in early pregnancy. Hum Reprod. 1998;13:1057–1062
- . Relationship between maternal serum VEGF concentration in early pregnancy and fetal and placental growth. Hum Reprod. 1999;14:1619–1623
- Levels of vascular endothelial growth factor are elevated in patients with ectopic pregnancy: is this a novel marker?. Fertil Steril. 1999;72:1013–1017
- The insulin-like growth factor dependent IGF binding protein-4 protease secreted by human fibroblasts is PAPP-A. Proc Natl Acad Sci USA. 1999;96:3149–3153
- In: Gabbe S, Niebyl J, Simpson JL editor. Gabbe obstetrics. Pennsylvania: Churchill: Livingstone; 2002;p. 23–26
- . VEGF is secreted angiogenic mitogen. Science. 1989;246:1306–1309
- . Maternal serum vascular growth factor levels in early ectopic and intrauterine pregnancies after in vitro fertilization treatment. Fertil Steril. 2004;82:309–313
- The value of a single combined measurement of VEGF, glycodelin, progesterone, PAPP-A, HPL and LIF for differentiating between ectopic and abnormal intrauterine pregnancy. Hum Reprod. 2005;20:3163–3166
- . Vascular endothelial growth factor (VEGF) and discrimination between abnormal intrauterine and ectopic pregnancy. Hum Reprod. 2002;17:3231–3234
- . Angiogenesis and the expression of VEGF in endometrium and placenta. Am J Reprod Immunol. 1997;37:21–29
- . Amniotic fluid soluble VEGF rec-1 in preeclampsia. Obstet Gynecol. 2000;95:353–357
- . Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen induced increases in uterine capillary permeability and growth. Endocrinology. 1993;133:829–832
- . Vascular endothelial growth factor modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia. Am J Physiol. 2000;27:2033–2042
- . Regulation of the vascular endothelial growth factor receptor flk-1/KDR by estradiol through VEGF in uterus. J Endocrinol. 2006;188:91–99
- . Serum estradiol as an aid in the diagnosis of ectopic pregnancy. Obstet Gynecol. 1990;76:1126–1129
- . Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol Cell Endocrinol. 1998;140:19–24
- Accuracy of single measurement of pregnancy-associated plasmaprotein-A, human chorionic gonadotropin and progesterone in the diagnosis of early pregnancy failure. Eur J Obstet Gynecol Reprod Biol. 2002;100:174–200
- . Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome. Prenat Diag. 2002;22:778–782
- . Biochemical discrimination of pathologic pregnancy from early, normal intrauterine gestation in symptomatic patients. Am J Clin Pathol. 1995;103:386–390
- . Serum progesterone and uterine curettage in differential diagnosis of ectopic pregnancy. Fertil Steril. 1992;57:456–457
- . Single serum progesterone as a screen for ectopic pregnancy: exchanging specificity and sensitivity to obtain optimal test performance. Fertil Steril. 1996;66:513–516
- . The accuracy of single serum progesterone measurement in the diagnosis of ectopic pregnancy: a meta-analysis. Hum Reprod. 1998;13:3220–3227
- . Progesterone synthesis by the human placenta. Placenta. 2005;26:273–281
E.N.U. has nothing to disclose. G.O. has nothing to disclose. A.K. has nothing to disclose. E.Z. has nothing to disclose. A.A. has nothing to disclose. M.U. has nothing to disclose.
PII: S0015-0282(08)00236-7
doi: 10.1016/j.fertnstert.2008.02.002
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Fertility and Sterility
Volume 91, Issue 5
, Pages 1657-1661
, May 2009

